DOMO Stock Analysis: Domo | NASDAQ
Software - Application | NASDAQ, USA | Market Cap: 151m USD | 12M Return: -75.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 4.87M
Qual. Beats: 0
Rev. Trend: -18.1%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 8 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Domo, Inc. (NASDAQ: DOMO) operates a cloud-based modern AI and data products platform that connects leadership to frontline employees through real-time data, systems, and people within an organization. The company is headquartered in American Fork, Utah, was incorporated in 2010, and went public in June 2018. It serves clients across financial services, healthcare, pharmaceuticals, energy, and technology industries, with operations spanning North America, Western Europe, Australia, Japan, and India. Domo maintains a strategic partnership with Altis Consulting to deliver data solutions focused on business outcomes.
The company operates within the Application Software sub-industry of the Information Technology sector, functioning as a business intelligence and data analytics provider. Like most peers in this space, Domo employs a Software-as-a-Service (SaaS) subscription model, delivering its platform to enterprise customers via the cloud. The company was originally incorporated as Domo Technologies, Inc. before adopting its current name in December 2011.
- AI-driven data platform adoption accelerates subscription revenue growth
- Competition intensifies from Microsoft Power BI and Snowflake in analytics market
- Path to profitability pressured by elevated operating costs and cash burn
| Net Income: -55.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 9.14 > 1.0 |
| NWC/Revenue: -80.31% < 20% (prev -36.04%; Δ -44.27% < -1%) |
| CFO/TA 0.05 > 3% & CFO 9.15m > Net Income -55.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.4m) vs 12m ago 9.26% < -2% |
| Gross Margin: 74.88% > 18% (prev 74.47%; Δ 0.41% > 0.5%) |
| Asset Turnover: 164.7% > 50% (prev 167.2%; Δ -2.41% > 0%) |
| Interest Coverage Ratio: -3.01 > 6 (EBIT TTM -40.2m / Interest Expense TTM 13.3m) |
| A: -1.30 (Total Current Assets 117.1m - Total Current Liabilities 372.6m) / Total Assets 196.6m |
| B: -7.94 (Retained Earnings -1.56b / Total Assets 196.6m) |
| C: -0.21 (EBIT TTM -40.2m / Avg Total Assets 193.1m) |
| D: -0.49 (Book Value of Equity -186.3m / Total Liabilities 382.9m) |
| Altman-Z'' = -36.32 = D |
| DSRI: 1.15 (Receivables 50.5m/43.9m, Revenue 318.1m/317.1m) |
| GMI: 0.99 (GM 74.47% / 74.88%) |
| AQI: 1.17 (AQ_t 0.21 / AQ_t-1 0.18) |
| SGI: 1.00 (Revenue 318.1m / 317.1m) |
| TATA: -0.33 (NI -55.5m - CFO 9.15m) / TA 196.6m) |
| Beneish M = -2.84 (Cap -4..+1) = A |
As of July 24, 2026, the stock is trading at USD 3.95 with a total of 30,782,408 shares traded. Over the past week, the price has changed by +18.62%, over one month by +76.34%, over three months by +3.95% and over the past year by -75.51%.
Current recommended Stop Loss: 3.00 (which is 24.1% or 2.9 ATR below the current price).
Domo has received a consensus analysts rating of 3.60. Therefore, it is recommended to hold DOMO.
- StrongBuy: 1
- Buy: 1
- Hold: 3
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 4.3 | 9.6% |
P/S = 0.474
P/B = 32.0279
Revenue TTM = 318.1m USD
EBIT TTM = -40.2m USD
EBITDA TTM = -25.2m USD
Long Term Debt = 126.5m USD (from longTermDebt, last fiscal year)
Short Term Debt = 144.8m USD (from shortTermDebt, last quarter)
Debt = 159.6m USD (from shortLongTermDebtTotal, last quarter) + Leases 11.3m
Net Debt = 126.3m USD (calculated: Debt 159.6m - CCE 33.4m)
Enterprise Value = 277.1m USD (150.8m + Debt 159.6m - CCE 33.4m)
Interest Coverage Ratio = -3.01 (Ebit TTM -40.2m / Interest Expense TTM 13.3m)
EV/FCF = 968.7x (Enterprise Value 277.1m / FCF TTM 286k)
FCF Yield = 0.10% (FCF TTM 286k / Enterprise Value 277.1m)
FCF Margin = 0.09% (FCF TTM 286k / Revenue TTM 318.1m)
Net Margin = -17.43% (Net Income TTM -55.5m / Revenue TTM 318.1m)
Gross Margin = 74.88% ((Revenue TTM 318.1m - Cost of Revenue TTM 79.9m) / Revenue TTM)
Gross Margin QoQ = 73.73% (prev 76.78%)
Tobins Q-Ratio = 1.41 (Enterprise Value 277.1m / Total Assets 196.6m)
Interest Expense / Debt = 8.36% (Interest Expense 13.3m / Debt 159.6m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -31.7m (EBIT -40.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.31 (Total Current Assets 117.1m / Total Current Liabilities 372.6m)
Debt / Equity = -0.86 (negative equity) (Debt 159.6m / totalStockholderEquity, last quarter -186.3m)
Debt / EBITDA = -5.02 (negative EBITDA) (Net Debt 126.3m / EBITDA -25.2m)
Debt / FCF = 441.5 (Net Debt 126.3m / FCF TTM 286k)
Total Stockholder Equity = -188.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -28.72% (Net Income -55.5m / Total Assets 196.6m)
RoE = 29.35% (negative equity) (Net Income TTM -55.5m / Total Stockholder Equity -188.9m)
RoCE = 64.35% (negative capital employed) (EBIT -40.2m / Capital Employed (Equity -188.9m + L.T.Debt 126.5m))
RoIC = 67.24% (negative operating profit) (NOPAT -31.7m / Invested Capital -47.2m)
WACC = 9.61% (E(150.8m)/V(310.4m) * Re(12.79%) + D(159.6m)/V(310.4m) * Rd(8.36%) * (1-Tc(0.21)))
Discount Rate = 12.79% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 99.18 | Cagr: 7.68%
[DCF] Terminal Value 71.14% ; FCFF base≈286k ; Y1≈287k ; Y5≈304k
[DCF] Fair Price = N/A (negative equity: EV 3.90m - Net Debt 126.3m = -122.4m; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.47 | # QB: 0
Revenue Correlation: -18.11 | Revenue CAGR: -0.05% | SUE: -0.46 | # QB: 0
EPS current Quarter (2026-07-31): EPS=0.00 | Chg30d=N/A | Revisions=-17% | Analysts=6
EPS next Quarter (2026-10-31): EPS=0.02 | Chg30d=N/A | Revisions=-17% | Analysts=6
EPS current Year (2027-01-31): EPS=0.06 | Chg30d=N/A | Revisions=+50% | GrowthEPS=+306.7% | GrowthRev=-1.5%
EPS next Year (2028-01-31): EPS=0.11 | Chg30d=-12.41% | Revisions=-12% | GrowthEPS=+74.2% | GrowthRev=+2.9%
[Analyst] Revisions Ratio: +0% (up=7, down=7)